Q2 2026 Holdings
Filed 2026-08-12 | 23 holdings | $645.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $283.9M | 8,020,928 | 44.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $51.7M | 276,000 | 8.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $30.5M | 260,500 | 4.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $27.5M | 206,500 | 4.3% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $25.7M | 90,020 | 4.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $23.2M | 671,209 | 3.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $21.3M | 23,000 | 3.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $20.1M | 37,120 | 3.1% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $16.9M | 110,000 | 2.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $16.4M | 425,000 | 2.5% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $14.9M | 909,474 | 2.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.3M | 220,000 | 2.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $12.5M | 134,429 | 1.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $11.0M | 355,800 | 1.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $10.8M | 212,500 | 1.7% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $10.5M | 108,000 | 1.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $10.5M | 5,050,000 | 1.6% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $10.3M | 720,000 | 1.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $9.7M | 370,000 | 1.5% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $7.5M | 1,608,815 | 1.2% |
| Inventiva SA(IVA) | ADS | 46124U107 | $7.4M | 1,967,171 | 1.2% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $5.4M | 47,500 | 0.8% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $4.4M | 175,050 | 0.7% |